ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 19, 2011, Pages 7938-7943

  Bollyky, Paul L ^a,b   Wu, Rebecca P ^a   Falk, Ben A ^a   Lord, James D ^a   Long, S Alice ^a   Preisinger, Anton ^a   Teng, Brandon ^a   Holt, Gregory E ^c   Standifer, Nathan E ^d   Braun, Kathleen R ^a   Xie, Cindy Fang ^a   Samuels, Peter L ^a   Vernon, Robert B ^a   Gebe, John A ^a   Wight, Thomas N ^a   Nepom, Gerald T ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 10; L SELECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPONTIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FATE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; EXTRACELLULAR MATRIX; HEALING IMPAIRMENT; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOREGULATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STEM CELL; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD44; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; EXTRACELLULAR MATRIX; FORKHEAD TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; HUMANS; HYALURONIC ACID; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OSTEOPONTIN; PRECURSOR CELLS, T-LYMPHOID; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

MURINAE;

EID: 79956352407     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017360108     Document Type: Article

References (36)

1. Roncarolo MG, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212:28-50. (Pubitemid 44116698)
2. Vieira PL, et al. (2004) IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172:5986-5993. (Pubitemid 38621199)
3. Groux H, et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742. (Pubitemid 27458961)
4. Awasthi A, et al. (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8:1380-1389. (Pubitemid 350131175)
5. Pedersen AE, Gad M, Walter MR, Claesson MH (2004) Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-dihydroxyvitamin D(3). Immunol Lett 91:63-69. (Pubitemid 38147747)
6. Kemper C, et al. (2003) Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388-392. (Pubitemid 36157938)
7. Levings MK, et al. (2005) Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105:1162-1169. (Pubitemid 40170889)
8. Hawrylowicz CM, O'Garra A (2005) Potential role of interleukin-10- secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5:271-283. (Pubitemid 40516153)
9. Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: An information-rich system. Eur J Cell Biol 85:699-715. (Pubitemid 44070579)
10. Bollyky PL, et al. (2007) Cutting edge: High molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol 179:744-747.
11. Bollyky PL, et al. (2009) CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J Immunol 183:2232-2241.
12. Bollyky PL, et al. (2009) Intact extracellular matrix and the maintenance of immune tolerance: High molecular weight hyaluronan promotes persistence of induced CD4+ CD25+ regulatory T cells. J Leukoc Biol 86:567-572.
13. Sakaguchi S, Setoguchi R, Yagi H, Nomura T (2006) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr Top Microbiol Immunol 305:51-66. (Pubitemid 47400264)
14. Asari A, Kanemitsu T, Kurihara H (2010) Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J Biol Chem 285:24751-24758.
15. Budd RC, et al. (1987) Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 138:3120-3129. (Pubitemid 17071880)
16. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995-1004.
17. Laurent TC, Fraser JR (1992) Hyaluronan. FASEB J 6:2397-2404.
18. Dong C, et al. (2001) ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409:97-101. (Pubitemid 32098632)
19. Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181.
20. Tsuji-Takayama K, et al. (2008) The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus. J Immunol 181:3897-3905.
21. Cantor H, Shinohara ML (2009) Regulation of T-helper-cell lineage development by osteopontin: The inside story. Nat Rev Immunol 9:137-141.
22. Hur EM, et al. (2007) Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 8:74-83. (Pubitemid 46242361)
23. Ashkar S, et al. (2000) Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287:860-864. (Pubitemid 30084330)
24. Heilmann K, et al. (2008) Osteopontin as two-sidedmediator of intestinal inflammation. J Cell Mol Med 13:1162-1174.
25. Prestwich GD, et al. (2006) Injectable synthetic extracellular matrices for tissue engineering and repair. Adv Exp Med Biol 585:125-133.
26. Najjam S, Gibbs RV, Gordon MY, Rider CC (1997) Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Cytokine 9:1013-1022. (Pubitemid 28026668)
27. Wrenshall LE, Platt JL, Stevens ET, Wight TN, Miller JD (2003) Propagation and control of T cell responses by heparan sulfate-bound IL-2. J Immunol 170:5470-5474. (Pubitemid 36617834)
28. Schönherr E, Hausser HJ (2000) Extracellular matrix and cytokines: A functional unit. Dev Immunol 7:89-101.
29. Lortat-Jacob H (2009) The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr Opin Struct Biol 19:543-548.
30. Bollyky PL, et al. (2010) Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapse. Cell Mol Immunol 7:211-220.
31. Puré E, Cuff CA (2001) A crucial role for CD44 in inflammation. Trends Mol Med 7:213-221. (Pubitemid 32822893)
32. Lesley J, Hascall VC, Tammi M, Hyman R (2000) Hyaluronan binding by cell surface CD44. J Biol Chem 275:26967-26975.
33. Fujii Y, Fujii K, Nakano K, Tanaka Y (2003) Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1. FEBS Lett 539:45-50. (Pubitemid 36351285)
34. Huet S, et al. (1989) CD44 contributes to T cell activation. J Immunol 143:798-801. (Pubitemid 19203800)
35. Wang KX, Denhardt DT (2008) Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 19:333-345.
36. Murugaiyan G, Mittal A, Weiner HL (2010) Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc Natl Acad Sci USA 107:11495-11500.